Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$731K Sell
477,821
-356,669
-43% -$542K ﹤0.01% 2995
2026
Q1
$1.51M Buy
834,490
+408,197
+96% +$706K ﹤0.01% 2493
2025
Q4
$575K Buy
+426,293
New +$607K ﹤0.01% 3170
2023
Q4
Sell
-34,341
Closed -$13.7K 2621
2023
Q3
$13.7K Sell
34,341
-49,531
-59% -$24.5K ﹤0.01% 2316
2023
Q2
$45.6K Sell
83,872
-75,133
-47% -$48.2K ﹤0.01% 1623
2023
Q1
$136K Buy
+159,005
New +$173K ﹤0.01% 1572

Other funds holding OCGN

Steven Cohen's OCGN Position: Q2 2026 in Review

Steven Cohen reduced its Ocugen (OCGN) stake by 43% in Q2 2026, selling an estimated $542K and leaving 477,821 shares worth $731K. The position accounts for ﹤0.01% of the portfolio, ranked #2995.

Steven Cohen first reported a position in OCGN in Q1 2023 and has held it in 6 quarters since. The position peaked at $1.51M in Q1 2026. 146 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Steven Cohen held 477,821 shares of Ocugen worth $731K as of Q2 2026.
  • Steven Cohen sold 356,669 Ocugen shares in Q2 2026, an estimated $542K.
  • Ocugen made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #2995 holding.
  • Steven Cohen first reported a position in Ocugen in Q1 2023 and has held it in 6 quarters since.
  • Steven Cohen's Ocugen position peaked at $1.51M in Q1 2026.
  • 146 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.